Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -23.91x is in line with its 5-year average of -25.42x, near the high end of its 5-year range (-449.46x–-8.31x).
26.37% below its 12-month average of -18.92x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -11.47x.
INTEREST COVERAGE RATIO
-23.91x
INTEREST COVERAGE RATIO AVG TTM
-18.92x
INTEREST COVERAGE RATIO AVG 3Y
-27.52x
INTEREST COVERAGE RATIO AVG 5Y
-25.42x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-26.37%
CURRENT VS 3Y AVG
+13.11%
CURRENT VS 5Y AVG
+5.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-271.27%
vs the sector median at left
Alpha Teknova, Inc.
Market Cap
$469.12M
Interest Coverage Ratio
-23.91x
TTM Avg
-18.92x
3Y Avg
-27.52x
5Y Avg
-25.42x
Market Cap
$467.90M
Interest Coverage Ratio
30.36x
TTM Avg
30.37x
3Y Avg
18.36x
5Y Avg
29.15x
Market Cap
$471.57M
Interest Coverage Ratio
-1.04x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$472.23M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$465.75M
Interest Coverage Ratio
-7.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$475.91M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$483.54M
Interest Coverage Ratio
5.63x
TTM Avg
4.06x
3Y Avg
3.16x
5Y Avg
2.54x
Market Cap
$452.54M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | $469.12M | -23.91x | -18.92x | -27.52x | -25.42x |
| Kamada Ltd. (KMDA)vs › | $467.90M | 30.36x | 30.37x | 18.36x | 29.15x |
| Cerus Corporation (CERS)vs › | $471.57M | -1.04x | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $471.65M | N/A | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | N/A | N/A | N/A | N/A |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | -7.21x | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | N/A | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 5.63x | 4.06x | 3.16x | 2.54x |
| NRC Health (NRC)vs › | $452.54M | 4.74x | 9.15x | 25.82x | 26.16x |
| Evolus, Inc. (EOLS)vs › | $486.01M | -1.91x | N/A | N/A | N/A |
Interest Coverage
-23.9x
Debt/Equity
0.44
Current Ratio
4.49
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -11.47x |
| 2026-03-31 | -19.63x |
| 2025-12-31 | -21.84x |
| 2025-09-30 | -21.14x |
| 2025-06-30 | -20.52x |
| 2025-03-31 | -34.47x |
| 2024-12-31 | -43.63x |
| 2024-09-30 | -52.71x |
| 2024-06-30 | -18.75x |
| 2024-03-31 | -55.08x |
| 2023-12-31 | -24.68x |
| 2023-09-30 | -11.08x |
| 2023-06-30 | -22.72x |
| 2022-03-31 | -449.46x |
| 2021-12-31 | -132.42x |
| 2021-09-30 | -15.25x |
| 2021-06-30 | -8.31x |
